Park Ha Biological Technology Co., Ltd.
BYAH
$1.05
$0.010.96%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 642.80K | 642.80K | 619.60K | 619.60K | 764.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 642.80K | 642.80K | 619.60K | 619.60K | 764.50K |
| Cost of Revenue | 42.00K | 42.00K | 29.30K | 29.30K | 48.60K |
| Gross Profit | 600.80K | 600.80K | 590.30K | 590.30K | 715.80K |
| SG&A Expenses | 2.71M | 2.71M | 10.44M | 10.44M | 356.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.86M | 2.86M | 10.48M | 10.48M | 413.80K |
| Operating Income | -2.22M | -2.22M | -9.86M | -9.86M | 350.70K |
| Income Before Tax | -2.21M | -2.21M | -9.83M | -9.83M | 350.10K |
| Income Tax Expenses | 50.90K | 50.90K | 89.50K | 89.50K | 135.20K |
| Earnings from Continuing Operations | -2.26M | -2.26M | -9.92M | -9.92M | 214.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.26M | -2.26M | -9.92M | -9.92M | 214.80K |
| EBIT | -2.22M | -2.22M | -9.86M | -9.86M | 350.70K |
| EBITDA | -2.17M | -2.17M | -9.85M | -9.85M | 356.40K |
| EPS Basic | -3.54 | -3.54 | -18.44 | -18.44 | 0.43 |
| Normalized Basic EPS | -2.16 | -2.16 | -11.42 | -11.42 | 0.44 |
| EPS Diluted | -3.54 | -3.54 | -18.44 | -18.44 | 0.43 |
| Normalized Diluted EPS | -2.16 | -2.16 | -11.42 | -11.42 | 0.44 |
| Average Basic Shares Outstanding | 640.00K | 640.00K | 537.70K | 537.70K | 500.00K |
| Average Diluted Shares Outstanding | 640.00K | 640.00K | 537.70K | 537.70K | 500.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |